{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:22:14Z","timestamp":1782490934423,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["mcpiqojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.mayocpiqo.2021.11.005","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T01:58:57Z","timestamp":1639965537000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Medications and Patient Factors Associated With Increased Readmission for Alcohol-Related Diagnoses"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3201-7283","authenticated-orcid":false,"suffix":"II","given":"Joseph C.","family":"Osborne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4572-9730","authenticated-orcid":false,"given":"Susan E.","family":"Horsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8783-0191","authenticated-orcid":false,"given":"Kristin C.","family":"Mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6212-8988","authenticated-orcid":false,"given":"Thomas C.","family":"Kingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9369-2242","authenticated-orcid":false,"given":"Robert W.","family":"Kirchoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3836-9375","authenticated-orcid":false,"given":"Jonathan G.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mayocpiqo.2021.11.005_bib27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1360-0443.2010.02899.x","article-title":"The relation between different dimensions of alcohol consumption and burden of disease: an overview","volume":"105","author":"Rehm","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.mayocpiqo.2021.11.005_bib29","unstructured":"National Institute on Alcohol Abuse and Alcoholism (NIAAA). Alcohol facts and statistics. Accessed July 26, 2020. Available: https:\/\/www.niaaa.nih.gov\/sites\/default\/files\/AlcoholFactsAndStats.pdf"},{"key":"10.1016\/j.mayocpiqo.2021.11.005_bib30","doi-asserted-by":"crossref","unstructured":"Sacks JJ, Gonzales KR, Bouchery EE, Tomedi LE, Brewer RD. 2010 National and state costs of excessive alcohol consumption. Am J Prev Med. 2015;49(5):e73-e79.","DOI":"10.1016\/j.amepre.2015.05.031"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2021.11.005_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/alcalc\/agaa018","article-title":"Predictors of readmission following outpatient treatment for alcohol use disorder","volume":"55","author":"Hansen","year":"2020","journal-title":"Alcohol Alcohol"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2021.11.005_bib7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/alcalc\/agy024","article-title":"Predictors of alcohol withdrawal readmissions","volume":"53","author":"Yedlapati","year":"2018","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2021.11.005_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0310057X1804600109","article-title":"The impact of alcohol-related admissions on resource use in critically ill patients from 2009 to 2015: an observational study","volume":"46","author":"Secombe","year":"2018","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.mayocpiqo.2021.11.005_bib9","doi-asserted-by":"crossref","unstructured":"Clark BJ, Rubinsky AD, Ho PM, et\u00a0al. Alcohol screening scores and the risk of intensive care unit admission and hospital readmission. Subst Abus. 37(3):466-473.","DOI":"10.1080\/08897077.2015.1137259"},{"issue":"14","key":"10.1016\/j.mayocpiqo.2021.11.005_bib10","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","article-title":"Rehospitalizations among patients in the Medicare fee-for-service program","volume":"360","author":"Jencks","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mayocpiqo.2021.11.005_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.pnpbp.2018.11.019","article-title":"Body mass index and craving predict 24-month hospital readmissions of alcohol-dependent in-patients following withdrawal","volume":"90","author":"Weinland","year":"2019","journal-title":"Prog Neuropsychopharmacology Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2021.11.005_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jamasurg.2013.700","article-title":"Increased admission for alcohol dependence after gastric bypass surgery compared with restrictive bariatric surgery","volume":"148","author":"\u00d6stlund","year":"2013","journal-title":"JAMA Surg"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2021.11.005_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016921","article-title":"Evaluating the predictive strength of the LACE index in identifying patients at high risk of hospital readmission following an inpatient episode: A retrospective cohort study","volume":"7","author":"Damery","year":"2017","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.mayocpiqo.2021.11.005_bib14","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1007\/s10620-020-06765-7","article-title":"Thirty-day readmission among patients with alcoholic acute pancreatitis","volume":"66","author":"Argueta","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2021.11.005_bib15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jhm.2568","article-title":"Predicting all-cause readmissions using electronic health record data from the entire hospitalization: Model development and comparison","volume":"11","author":"Nguyen","year":"2016","journal-title":"J\u00a0Hosp Med"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2021.11.005_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1062860617750469","article-title":"An initial assessment of the utility of validated alcohol and drug screening tools in predicting 30-day readmission to adult general medicine wards","volume":"33","author":"Gerke","year":"2018","journal-title":"Am J Med Qual"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2021.11.005_bib17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00000542-200108000-00007","article-title":"A\u00a0double-blind, randomized comparison of IV lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model","volume":"95","author":"Barr","year":"2001","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.mayocpiqo.2021.11.005_bib18","first-page":"20","article-title":"Benzodiazepines II: waking up on sedatives: providing optimal care when inheriting benzodiazepine prescriptions in transfer patients","volume":"7","author":"Guina","year":"2018","journal-title":"J\u00a0Clin Med"},{"issue":"3S Suppl 1","key":"10.1016\/j.mayocpiqo.2021.11.005_bib19","first-page":"1","article-title":"The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management [published correction appears in J Addict Med. 2020 Sep\/Oct;14(5):e280]","volume":"14","year":"2020","journal-title":"J Addict Med"},{"key":"10.1016\/j.mayocpiqo.2021.11.005_bib20","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.1016\/j.drugalcdep.2020.108171","article-title":"Pain-related anxiety, sex, and co-use of alcohol and prescription opioids among adults with chronic low back pain","volume":"214","author":"LaRowe","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2021.11.005_bib21","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/add.13324","article-title":"Gabapentin misuse, abuse, and diversion: a systematic review","volume":"111","author":"Smith","year":"2016","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2021.11.005_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/13543784.2018.1417383","article-title":"Gabapentin for the treatment of alcohol use disorder","volume":"27","author":"Mason","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"issue":"8","key":"10.1016\/j.mayocpiqo.2021.11.005_bib31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jama.2018.11406","article-title":"Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review","volume":"320","author":"Kranzler","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2021.11.005_bib23","first-page":"39","article-title":"Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence clinical guideline","volume":"4","year":"2011","journal-title":"Adv Dual Diagn"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2021.11.005_bib24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/alcalc\/agr079","article-title":"Exploring treatment attendance and its relationship to outcome in a randomized controlled trial of treatment for alcohol problems: secondary analysis of the UK alcohol treatment trial (UKATT)","volume":"46","author":"Dale","year":"2011","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2021.11.005_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.35946\/arcr.v40.1.01","article-title":"Alcohol use disorder and depressive disorders","volume":"40","author":"Mchugh","year":"2019","journal-title":"Alcohol Res"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2021.11.005_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13011-015-0045-y","article-title":"Prescription for antidepressant in reducing future alcohol-related readmission in patients suffering from depression and alcohol use disorder: a retrospective medical record review","volume":"10","author":"Chan","year":"2015","journal-title":"Subst Abus Treat Prev Policy"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2021.11.005_bib26","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/ajhp\/zxz018","article-title":"Using artificial intelligence in health-system pharmacy practice: finding new patterns that matter","volume":"76","author":"Flynn","year":"2019","journal-title":"Am J Health Syst Pharm"}],"container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454821001624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454821001624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:10:22Z","timestamp":1762870222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542454821001624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2542454821001624"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2021.11.005","relation":{},"ISSN":["2542-4548"],"issn-type":[{"value":"2542-4548","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medications and Patient Factors Associated With Increased Readmission for Alcohol-Related Diagnoses","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings: Innovations, Quality & Outcomes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2021.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.","name":"copyright","label":"Copyright"}]}}